Security Snapshot

VANECK ETF TRUST - CHINA BOND ETF (CBON) Institutional Ownership

CUSIP: 92189F379

13F Institutional Holders and Ownership History from Q2 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

11

Shares (Excl. Options)

101,047

Price

$23.32

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-72,535
Value change
-$1,667,406
Number of holders
11
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$23.57
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CBON - VANECK ETF TRUST - CHINA BOND ETF is tracked under CUSIP 92189F379.
  • 11 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 13 to 11 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $3,964,524 to $2,356,289.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 11 institutions filings for Q1 2026.

Open SEC evidence

Security key

92189F379

Latest holder period

Q1 2026

13F holders

11

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 11 institutional investors reported holding 101,047 shares of VANECK ETF TRUST - CHINA BOND ETF (CBON).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
40
Latest
Q1 2026
Rows shown
1-25 of 40
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 101,047 $2,356,289 -$1,667,406 $23.32 11
2025 Q4 173,582 $3,964,524 -$44,250 $22.84 13
2025 Q3 174,543 $3,906,282 +$1,442,238 $22.38 10
2025 Q2 110,100 $2,464,049 -$1,013,062 $22.38 7
2025 Q1 155,506 $3,428,923 -$986,230 $22.05 6
2024 Q4 200,267 $4,411,879 +$351,489 $22.03 9
2024 Q3 174,742 $3,984,128 +$58,072 $22.80 7
2024 Q2 173,760 $3,795,037 -$1,783,598 $21.84 10
2024 Q1 255,424 $5,576,398 +$49,041 $21.83 9
2023 Q4 253,052 $5,592,566 -$700,891 $22.10 12
2023 Q3 285,088 $6,138,731 -$2,252,011 $21.52 9
2023 Q2 389,810 $8,459,946 +$2,332,286 $21.69 11
2023 Q1 281,942 $6,345,128 -$5,151,643 $22.50 10
2022 Q4 515,026 $11,403,704 -$22,266,391 $22.14 15
2022 Q3 1,523,706 $33,448,815 +$4,008,534 $21.94 18
2022 Q2 1,338,113 $31,315,140 -$23,722,591 $23.40 20
2022 Q1 2,286,061 $56,304,669 +$30,492,855 $24.63 25
2021 Q4 1,040,514 $25,688,162 +$7,000,801 $24.68 21
2021 Q3 664,232 $16,198,942 -$5,564,633 $24.38 18
2021 Q2 895,859 $21,579,058 +$7,768,012 $24.09 22
2021 Q1 574,772 $13,650,000 +$10,652,707 $23.74 18
2020 Q4 126,212 $3,034,000 +$2,162,826 $24.03 6
2020 Q3 37,794 $870,000 -$872,927 $23.25 6
2020 Q2 75,801 $1,686,000 +$804,545 $23.17 3
2020 Q1 39,645 $871,000 -$331,460 $21.98 3
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .